Recent Progress of Artificial Cells in Structure Design, Functionality and the Prospects in Food Biotechnology

Overview

Journal Mater Today Bio

Specialty Biomedical Engineering

Date 2025 Mar 3

PMID 40026621

Authors

Li Li

Xiaolin Yao

Guoliang Li

Qianqian Guo

Juan Yue

Wenguang Liu

Yapeng Fang

Adam Midgley

Mouming Zhao

Katsuyoshi Nishinari

Affiliations

Soon will be listed here.

Abstract

Artificial cells have bridged the gap between non-living systems and biological cells. In recent years, artificial cells designed to simulate cellular structure and function have garnered significant attention. These artificial cells demonstrate vast potential for advancements in various biomedical areas, including simulating cell structure and function, creating innovative biosensors, facilitating bioactives transport, enabling micro and nanoreactors, and improving the targeted therapy for chronic foodborne diseases. In the interdisciplinary field of artificial cell construction, based on their constituent components, these systems can be categorized into lipid/polymer vesicles, coacervate, colloidosome, and metal-organic framework (MOF) artificial cells. They are anticipated to significantly enhance advancements in food science, particularly in cellular structure optimization, precise nutrition delivery, targeted nutrient release, and rapid detection methods. Consequently, this paper will comprehensively cover the historical background, fabrication techniques, and structural characteristics of artificial cells. From a functional design perspective, this review examines the growth and division mechanisms, energy production processes, encapsulation and reaction vessels, carriers, and information exchange systems of artificial cells. Ultimately, it provides a comprehensive evaluation of the safety of artificial cells from both biological and environmental viewpoints, to introduce and expand the application scenarios of this innovative biotechnology in food science.

References

Chen C, Wilson T . The phospholipid requirement for activity of the lactose carrier of Escherichia coli. J Biol Chem. 1984; 259(16):10150-8. View

Pelletier J, Sun L, Wise K, Assad-Garcia N, Karas B, Deerinck T . Genetic requirements for cell division in a genomically minimal cell. Cell. 2021; 184(9):2430-2440.e16. DOI: 10.1016/j.cell.2021.03.008. View

Muraoka T, Umetsu K, Tabata K, Hamada T, Noji H, Yamashita T . Mechano-Sensitive Synthetic Ion Channels. J Am Chem Soc. 2017; 139(49):18016-18023. DOI: 10.1021/jacs.7b09515. View

Qiao Y, Li M, Booth R, Mann S . Predatory behaviour in synthetic protocell communities. Nat Chem. 2017; 9(2):110-119. DOI: 10.1038/nchem.2617. View

Gaur D, Dubey N, Tripathi B . Biocatalytic self-assembled synthetic vesicles and coacervates: From single compartment to artificial cells. Adv Colloid Interface Sci. 2021; 299:102566. DOI: 10.1016/j.cis.2021.102566. View

Taylor P, Davies J . A review of the growing risk of vitamin D toxicity from inappropriate practice. Br J Clin Pharmacol. 2018; 84(6):1121-1127. PMC: 5980613. DOI: 10.1111/bcp.13573. View

Godino E, Lopez J, Foschepoth D, Cleij C, Doerr A, Castella C . De novo synthesized Min proteins drive oscillatory liposome deformation and regulate FtsA-FtsZ cytoskeletal patterns. Nat Commun. 2019; 10(1):4969. PMC: 6823393. DOI: 10.1038/s41467-019-12932-w. View

Sproncken C, Liu P, Monney J, Fall W, Pierucci C, Scholten P . Large-area, self-healing block copolymer membranes for energy conversion. Nature. 2024; 630(8018):866-871. PMC: 11208134. DOI: 10.1038/s41586-024-07481-2. View

Gebicki J, Hicks M . Ufasomes are stable particles surrounded by unsaturated fatty acid membranes. Nature. 1973; 243(5404):232-4. DOI: 10.1038/243232a0. View

10.

McClements D, Xiao H . Is nano safe in foods? Establishing the factors impacting the gastrointestinal fate and toxicity of organic and inorganic food-grade nanoparticles. NPJ Sci Food. 2019; 1:6. PMC: 6548419. DOI: 10.1038/s41538-017-0005-1. View

11.

Chang T . Pharmaceutical and therapeutic applications of artificial cells including microencapsulation. Eur J Pharm Biopharm. 1998; 45(1):3-8. DOI: 10.1016/S0939-6411(97)00117-3. View

12.

Liu S, Zhang Y, Li M, Xiong L, Zhang Z, Yang X . Enzyme-mediated nitric oxide production in vasoactive erythrocyte membrane-enclosed coacervate protocells. Nat Chem. 2020; 12(12):1165-1173. DOI: 10.1038/s41557-020-00585-y. View

13.

Gibson D, Glass J, Lartigue C, Noskov V, Chuang R, Algire M . Creation of a bacterial cell controlled by a chemically synthesized genome. Science. 2010; 329(5987):52-6. DOI: 10.1126/science.1190719. View

14.

Masiulis S, Desai R, Uchanski T, Martin I, Laverty D, Karia D . GABA receptor signalling mechanisms revealed by structural pharmacology. Nature. 2019; 565(7740):454-459. PMC: 6370056. DOI: 10.1038/s41586-018-0832-5. View

15.

Yewdall N, Mason A, van Hest J . The hallmarks of living systems: towards creating artificial cells. Interface Focus. 2018; 8(5):20180023. PMC: 6227776. DOI: 10.1098/rsfs.2018.0023. View

16.

Xu C, Martin N, Li M, Mann S . Living material assembly of bacteriogenic protocells. Nature. 2022; 609(7929):1029-1037. DOI: 10.1038/s41586-022-05223-w. View

17.

Liu S, Zhang Y, He X, Li M, Huang J, Yang X . Signal processing and generation of bioactive nitric oxide in a model prototissue. Nat Commun. 2022; 13(1):5254. PMC: 9448809. DOI: 10.1038/s41467-022-32941-6. View

18.

Surovtsev I, Jacobs-Wagner C . Subcellular Organization: A Critical Feature of Bacterial Cell Replication. Cell. 2018; 172(6):1271-1293. PMC: 5870143. DOI: 10.1016/j.cell.2018.01.014. View

19.

Xu Q, Zhang Z, Lui P, Lu L, Li X, Zhang X . Preparation and biomedical applications of artificial cells. Mater Today Bio. 2023; 23:100877. PMC: 10701372. DOI: 10.1016/j.mtbio.2023.100877. View

20.

Ayub M, Bayley H . Engineered transmembrane pores. Curr Opin Chem Biol. 2016; 34:117-126. PMC: 5123773. DOI: 10.1016/j.cbpa.2016.08.005. View